From Genome Exploration to Drug Development

Pharmaceutical Technology, Pharmaceutical Technology-06-02-2003, Volume 27, Issue 6

FDA's plan to establish pharmacogenomic policies spurs concerns among manufacturers, particularly in regard to how the policies will affect new-drug testing and approval.